Navigation Links
New biomedical engineering chair earns high honors
Date:2/25/2010

HOUSTON, Feb. 25, 2010 Just weeks into his post as John S. Dunn Distinguished Professor and founding chair of the University of Houston's new department of biomedical engineering, Metin Akay is already being recognized.

He was selected and recently inducted into two prestigious engineering and science organizations the American Association for the Advancement of Science (AAAS) and the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE). Internationally known, Akay was recognized Feb. 20 at the AAAS annual meeting in San Diego and Feb. 22 at the annual AIMBE meeting in Washington, D.C.

Of the 531 new AAAS fellows selected, Akay is one of 48 in the engineering section. His contributions to biomedical engineering research and education, specifically his work in informatics and neural engineering, earned him a fellowship with the association. AAAS is the world's largest general scientific society and publisher of the prominent journal Science.

For his AIMBE honor, Akay was selected for his contributions to the fields of neural and cardiovascular engineering. He was among 55 elected by AIMBE into the College of Fellows, which advocates for public policies facilitating progress in medical and biological research and development to benefit the public. Akay and his fellow inductees, according to AIMBE, represent some of the most imaginative and distinguished medical and biological engineers in the field. Their contributions have had major impacts in biomedical devices and processes, treatment of diseases, and public policy related to all aspects of medical and biological engineering.

These two honors come on the heels of Akay becoming the founding chair of UH's new biomedical engineering department last month. This is the first new department established at the Cullen College of Engineering at UH in more than 35 years.

Embracing the challenge of converting the college's longstanding biomedical program into a department, Akay has many goals in his new role at UH. In addition to increasing the visibility of the department, he anticipates adding as many as 12 faculty in the next five years, creating a distinguished lecture series, enhancing the program's offerings with a Ph.D. option in addition to existing bachelor's and master's degree tracks, and stimulating research collaborations with the Texas Medical Center.

Akay's endowed chair position is funded by the John S. Dunn Research Foundation and was created to help lead research initiatives at the university, as well as play a prominent role in the Institute for Biomedical Imaging Science the research partnership formed by UH, The Methodist Hospital and Weill Cornell Medical College. Akay says a significant part of this includes establishing a health care focused academic curriculum and entrepreneurship environment that meet the demands and requirements of the ever-changing global economy that influences health care technology, management and delivery. He plans to develop new academic and research fields that include biomedical imaging, neural and cognitive engineering, and genomics and proteomics science and engineering.

"Developments in science, engineering and technology have stimulated interdisciplinary research and collaborations among engineers, physicians, computer scientists and biologists," Akay said at a recent public gathering. "We are in the midst of these scientific and technological advancements, and it is an exciting time to be in the biomedical field."

Akay is a native of Turkey who earned his Ph.D. from Rutgers University in 1990. He was most recently a professor and former interim chair at Arizona State University's Harrington Department of Bioengineering before coming to UH in January 2010.

"The Cullen College of Engineering is uniquely positioned to play a major role in biomedical sciences in the Houston area," said Joseph W. Tedesco, Elizabeth D. Rockwell Endowed Chair and dean. "We are excited that Metin Akay is leading our academic and research efforts in biomedical engineering at the University of Houston."


'/>"/>

Contact: Lisa Merkl
lkmerkl@uh.edu
713-743-8192
University of Houston
Source:Eurekalert  

Related biology news :

1. New material mimics bone to create better biomedical implants
2. Finland invests €1.85 million in pan-European infrastructure for biomedical research
3. OSA to launch new journal: Biomedical Optics Express
4. Biomedical Engineering Societys new journal to be published by Springer
5. Duke biomedical scientists win 2 highly prized NIH Directors Awards
6. Qatar home to world-class biomedical research program
7. Virginia Tech biomedical engineering team to study knee ligament sprains
8. Boron-based compounds trick a biomedical protein
9. NIH stimulus funding supports Emory biomedical scientists
10. Axel Ullrich named winner of 2009 Dr. Paul Janssen Award for Biomedical Research
11. Canadian synchrotron conference sheds light on new biomedical research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New biomedical engineering chair earns high honors
(Date:2/2/2017)... Feb. 1, 2017  Central to its deep ... advances worldwide, The Japan Prize Foundation today announced ... have pushed the envelope in their respective fields ... Three scientists are being recognized with the 2017 ... not only contribute to the advancement of science ...
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)...  Crossmatch, a leading provider of security and identity ... combatting fraud, waste and abuse in assistance operations around ... on Disaster Relief conference in Panama City ... and foreign assistance organizations throughout Latin America ... a largely unacknowledged problem in the foreign assistance and ...
Breaking Biology News(10 mins):
(Date:2/16/2017)... -- ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology company harnessing the ... for triple negative breast cancer (TNBC), announced today their completion ... program. The YEi Start in France ... grow their business in France and ... to complete an intensive one week immersion in ...
(Date:2/16/2017)... 2017   Capricor Therapeutics, Inc. (NASDAQ: ... developing first-in-class biological therapies for cardiac and other ... to terminate its license agreement with the Mayo ... Cenderitide. "Our decision to return these ... our efforts to advance our core cell and ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
(Date:2/16/2017)... , ... February 16, 2017 ... ... Molecular Research Inc. has further extended its industry leading Biochemistry Services specifically ... offers state-of-the-art cGMP techniques and methods for the biochemical and biosimilar ...
Breaking Biology Technology: